المؤلفون: Marrie, Ruth Ann^{Aff1, Aff2, IDs4158202200686x_cor1}, Allegretta, Mark, Barcellos, Lisa F.^{Aff4, Aff5}, Bebo, Bruce, Calabresi, Peter A., Correale, Jorge, Davis, Benjamin, De Jager, Philip L., Gasperi, Christiane, Greenbaum, Carla, Helme, Anne, Hemmer, Bernhard^{Aff10, Aff13}, Kanellis, Pamela, Kostich, Walter, Landsman, Douglas, Lebrun-Frenay, Christine, Makhani, Naila, Munger, Kassandra L., Okuda, Darin T., Ontaneda, Daniel, Postuma, Ronald B., Quandt, Jacqueline A., Roman, Sharon, Saidha, Shiv, Sormani, Maria Pia, Strum, Jon, Valentine, Pamela, Walton, Clare, Zackowski, Kathleen M., Zhao, Yinshan, Tremlett, Helen

المصدر: Nature Reviews Neurology. 18(9):559-572

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Kalb, Rosalind C., Miller, Deborah, Strum, Jon, Loud, Sara

المصدر: International Journal of MS Care; Nov/Dec2023, Vol. 25 Issue 6, p273-277, 5p

مصطلحات موضوعية: MULTIPLE sclerosis diagnosis, SERVICES for caregivers, PSYCHOLOGY of caregivers, INFORMATION resources, MEDICAL needs assessment

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Thompson, Alan, Carroll, William, Ciccarelli, Olga, Comi, Giancarlo, Cross, Anne H., Donnelly, Alexis A., Feinstein, Anthony, Fox, Robert J, Helme, Anne, Hohlfeld, Reinhard, Hyde, Robert, Kanellis, Pamela, Landsman, Douglas, Lubetzki, Catherine, Marrie, Ruth Ann, Morahan, Julia, Montalban, Xavier, Musch, Bruno, Rawlings, Sarah, Salvetti, Marco, Sellebjerg, Finn, Sincock, Caroline, Smith, Kathryn E, Strum, Jon, Zaratin, Paola, Coetzee, Timothy, Universitat Autònoma de Barcelona

المصدر: Thompson, A J, Carroll, W, Ciccarelli, O, Comi, G, Cross, A, Donnelly, A, Feinstein, A, Fox, R J, Helme, A, Hohlfeld, R, Hyde, R, Kanellis, P, Landsman, D, Lubetzki, C, Marrie, R A, Morahan, J, Montalban, X, Musch, B, Rawlings, S, Salvetti, M, Sellebjerg, F, Sincock, C, Smith, K E, Strum, J, Zaratin, P & Coetzee, T 2022, ' Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal ', Multiple Sclerosis Journal, vol. 28, no. 1, pp. 16-28 . https://doi.org/10.1177/13524585211059766
Multiple Sclerosis (Houndmills, Basingstoke, England)

مصطلحات موضوعية: medicine.medical_specialty, Biomedical Research, progressive, Primary progressive, Multiple sclerosis, chemistry.chemical_compound, DOUBLE-BLIND, Physical medicine and rehabilitation, Progressive, MRI MEASURES, Humans, Medicine, NEUROFILAMENT LIGHT LEVELS, Progressive multiple sclerosis, Future Perspectives, OUTCOMES, PLACEBO, Progression, business.industry, DISABILITY, MULTIPLE-SCLEROSIS, NATURAL-HISTORY, Multiple Sclerosis, Chronic Progressive, medicine.disease, EFFICACY, progressive multiple sclerosis, Siponimod, Alliance, Neurology, chemistry, Research Design, Quality of Life, Ocrelizumab, progression, Neurology (clinical), business, MATTER, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d2ee819650ab1ddacd2946753c187e1
https://ddd.uab.cat/record/275819

المؤلفون: Thompson AJ; University College London, London, UK., Carroll W; The University of Western Australia, Perth, WA, Australia., Ciccarelli O; University College London, London, UK., Comi G; Vita-Salute San Raffaele University, Milan, Italy., Cross A; Washington University in St. Louis, St. Louis, MO, USA., Donnelly A; International Progressive MS Alliance, Dublin, Ireland., Feinstein A; Sunnybrook Research Institute, Toronto, ON, Canada., Fox RJ; Cleveland Clinic, Cleveland, OH, USA., Helme A; MS International Federation, London, UK., Hohlfeld R; Munich Cluster for Systems Neurology, Ludwig Maximilian University of Munich, Munich, Germany., Hyde R; Biogen, Cambridge, MA, USA., Kanellis P; MS Society of Canada, Toronto, ON, Canada., Landsman D; National Multiple Sclerosis Society, New York, NY, USA., Lubetzki C; Salpêtrière Hospital, Paris, France., Marrie RA; University of Manitoba, Winnipeg, MB, Canada., Morahan J; MS Research Australia, North Sydney, NSW, Australia., Montalban X; Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain., Musch B; Genentech, San Francisco, CA, USA., Rawlings S; MS Society, London, UK., Salvetti M; Department of Neurosciences, Mental Health and Sensory Organs, Centre for Experimental Neurological Therapies (CENTERS), Sapienza University of Rome, Rome, Italy/Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli, Italy., Sellebjerg F; Copenhagen University Hospital-Rigshospitalet, Glostrup, Denmark., Sincock C; International Progressive MS Alliance, Glasgow, UK., Smith KE; International Progressive MS Alliance, Lyme, CT, USA., Strum J; International Progressive MS Alliance, Los Angeles, CA, USA., Zaratin P; Italian Multiple Sclerosis Foundation, Genoa, Italy., Coetzee T; National Multiple Sclerosis Society, New York, NY, USA.

المصدر: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2022 Jan; Vol. 28 (1), pp. 16-28. Date of Electronic Publication: 2021 Dec 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE

مواضيع طبية MeSH: Biomedical Research* , Multiple Sclerosis*/drug therapy , Multiple Sclerosis, Chronic Progressive*/drug therapy, Humans ; Quality of Life ; Research Design